Form 4 for ELV Elevance Health
Accepted 2024-10-18 00:00:00 ET · period of report 2024-10-18 · accession 0001156039-24-000124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-18 | 2024-10-18 | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | S - Sale | $432.14 | -7,417 | 8,423 | -47% | -$3.21M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-18 | S | D | 7,417 | $432.14 | 8,423 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $432.08 to $432.32. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |